Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

Abstract

The research was aimed to assess use of proven eff ective secondary preventive drugs (antiplatelet drugs, β blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke.

Description

Keywords

Cardiovascular disease, Epidemiology, Surveys, Drugs, Income levels, Rural areas, Urban Areas, Angiotensin

Citation

Yusuf, S. et al (2011). Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet, 378: pp.1231-1243

Endorsement

Review

Supplemented By

Referenced By